Clinical Study
Statin as a Combined Therapy for Advanced-Stage Ovarian Cancer: A Propensity Score Matched Analysis
Table 2
Univariable and multivariable analysis: risk of mortality.
| Characteristics | Univariable analysis | Multivariable analysis | HR (95% CI) |
| Age (≥65/<65 years) | 0.535 | 0.734 | 1.176 (0.461–2.999) | FIGO stage (IV/III) | 0.958 | 0.359 | 1.614 (0.581–4.485) | Tumor grade (G3/G1-2) | 0.254 | 0.193 | 2.558 (0.622–10.513) | Histological subtype (Epithelial/nonepithelial) | 0.653 | 0.752 | 1.250 (0.315–4.964) | Cytoreductive surgery (Residual tumor > 1/≤1 cm) | 0.013 | 0.002 | 5.460 (1.894–15.742) | Statin (nonusage/usage) | 0.966 | 0.255 | 1.764 (0.664–4.682) |
|
|